Drug:
Reaction: SEIZURE
20260101 - 20261231
No. 3801 - 3900
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 3801 | 26364093 |
KR |
49 | 2 |
Seizure, Syncope, |
||||
IPRATROPIUM BROMIDE, ALBUTEROL SULFATE, |
||||
| 3802 | 26364605 |
32 | 2 | |
Completed suicide, Toxicity to various agents, Cardiac arrest, Pulmonary congestion, Pulmonary oedema, Blood gases abnormal, Electrocardiogram QRS complex prolonged, Electrocardiogram QT prolonged, Hypotension, Somnolence, Seizure, |
||||
AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, TOPIRAMATE, SPIRONOLACTONE, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, |
||||
| 3803 | 26364702 |
US |
48 | 2 |
Seizure, |
||||
DIROXIMEL FUMARATE, AMLODIPINE, MELOXICAM, MELOXICAM, NITROFURANTOIN, NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), TIZANIDINE, PREGABALIN, PREGABALIN, LACOSAMIDE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, |
||||
| 3804 | 26364999 |
US |
||
Seizure, Drug level below therapeutic, Treatment noncompliance, |
||||
PHENYTOIN SODIUM, TOPIRAMATE, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, |
||||
| 3805 | 26365031 |
EU |
20 | 2 |
Loss of consciousness, Electrocardiogram QT prolonged, Seizure, Intentional self-injury, Sinus tachycardia, Intentional overdose, |
||||
OLANZAPINE, BUPROPION HYDROCHLORIDE, QUETIAPINE, |
||||
| 3806 | 26365083 |
EU |
||
Seizure, Altered state of consciousness, |
||||
| 3807 | 26365116 |
10 | ||
Pulmonary valve incompetence, Seizure, Cardiac valve disease, Illness, Red blood cell count decreased, White blood cell count decreased, Weight increased, Drug ineffective, |
||||
| 3808 | 26365145 |
JP |
8 | 1 |
Infusion related reaction, Seizure, Pyrexia, Dermatitis acneiform, Drug hypersensitivity, Off label use, |
||||
AMIVANTAMAB-VMJW, AMIVANTAMAB-VMJW, AMIVANTAMAB-VMJW, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), OSIMERTINIB, OSIMERTINIB, ATEZOLIZUMAB, BEVACIZUMAB, |
||||
| 3809 | 26365606 |
EU |
69 | 1 |
Toxicity to various agents, Acute kidney injury, Seizure, Metabolic acidosis, Drug interaction, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, RITONAVIR, RITONAVIR 100 MG, BASILIXIMAB, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, |
||||
| 3810 | 26365810 |
US |
2 | |
Seizure, Hypotension, |
||||
OSIMERTINIB, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, AMLODIPINE BESYLATE, |
||||
| 3811 | 26365960 |
US |
76 | 2 |
Seizure, |
||||
POMALIDOMIDE, AMLODIPINE, ASCORBIC ACID, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BIOTIN, CYANOCOBALAMIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, FERROUS SULFATE, DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, MAGNESIUM OXIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CLOPIDOGREL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, ERGOCALCIFEROL, ZOLEDRONIC ACID, |
||||
| 3812 | 26366141 |
CA |
84 | 2 |
Atrial fibrillation, Seizure, Blood pressure systolic increased, Gait disturbance, Somnolence, Cystitis, Fatigue, |
||||
RITUXIMAB-PVVR, RITUXIMAB-PVVR, RITUXIMAB-PVVR, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALENDRONATE SODIUM, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, |
||||
| 3813 | 26366223 |
EU |
1 | |
Seizure, Drug ineffective, |
||||
LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, |
||||
| 3814 | 26366730 |
2 | ||
Corpus callosotomy, COVID-19, Seizure, Pericardial effusion, Gastrostomy tube removal, Drug ineffective, |
||||
FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, LEVETIRACETAM, LEVETIRACETAM, ZONISAMIDE, LACOSAMIDE, |
||||
| 3815 | 26366864 |
US |
33 | 1 |
Seizure, Fear of injection, Incorrect dose administered, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 3816 | 26366882 |
US |
2 | |
Seizure, Suicide attempt, Eating disorder, Abnormal behaviour, Drug dependence, |
||||
DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, |
||||
| 3817 | 26367104 |
US |
||
Stereotactic electroencephalography, Fall, Seizure, |
||||
CENOBAMATE, CENOBAMATE, |
||||
| 3818 | 26367106 |
US |
||
Seizure, Seizure, Off label use, Product dose omission issue, Product use issue, |
||||
CENOBAMATE, CENOBAMATE, CENOBAMATE, CENOBAMATE, CENOBAMATE, CENOBAMATE, CENOBAMATE, LEVETIRACETAM, LACOSAMIDE, |
||||
| 3819 | 26367189 |
US |
1 | |
Status dystonicus, Seizure, |
||||
LEVETIRACETAM, ZONISAMIDE, |
||||
| 3820 | 26367454 |
EU |
85 | 1 |
General physical health deterioration, Malignant neoplasm progression, Renal cancer, Seizure, Generalised tonic-clonic seizure, Basal cell carcinoma, Arthritis, Prostatic adenoma, Hyperuricaemia, |
||||
PAZOPANIB HYDROCHLORIDE, |
||||
| 3821 | 26368003 |
GB |
||
Seizure, Insomnia, |
||||
CENOBAMATE, |
||||
| 3822 | 26368022 |
CA |
85 | 1 |
Death, Muscle rigidity, Device use error, Catheter site pain, Hypersomnia, Device difficult to use, Freezing phenomenon, Gaze palsy, Atrial flutter, Vascular occlusion, Seizure, Cerebrovascular accident, |
||||
FOSCARBIDOPA/FOSLEVODOPA, EZETIMIBE, INSULIN GLARGINE, DUTASTERIDE, |
||||
| 3823 | 26368061 |
GB |
52 | 2 |
Seizure, |
||||
LOSARTAN, |
||||
| 3824 | 26368204 |
GB |
1 | 2 |
Pyrexia, Seizure, |
||||
| 3825 | 26368277 |
|||
Seizure, Infection, |
||||
FENFLURAMINE, VALPROIC ACID, STIRIPENTOL, STIRIPENTOL, TOPIRAMATE, TOPIRAMATE, |
||||
| 3826 | 26368389 |
US |
||
Seizure, |
||||
LUMATEPERONE, |
||||
| 3827 | 26368439 |
US |
2 | |
Seizure, |
||||
LUMATEPERONE, LUMATEPERONE, |
||||
| 3828 | 26368691 |
68 | ||
Seizure, Therapy interrupted, Insurance issue, |
||||
BRIVARACETAM, BRIVARACETAM INJECTION, LACOSAMIDE, |
||||
| 3829 | 26363108 |
US |
66 | 2 |
Seizure, Physical examination abnormal, Oxygen saturation abnormal, |
||||
ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, |
||||
| 3830 | 26363225 |
US |
2 | |
Seizure, |
||||
CANNABIDIOL, |
||||
| 3831 | 26363992 |
US |
||
Seizure, |
||||
VENETOCLAX, |
||||
| 3832 | 26362188 |
EU |
1 | |
Seizure, Drug ineffective, |
||||
LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, |
||||
| 3833 | 26362716 |
RU |
71 | 2 |
Seizure, Headache, |
||||
EMPAGLIFLOZIN, TICAGRELOR, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 3834 | 26363069 |
US |
6 | 1 |
Cardio-respiratory arrest, Brain injury, Seizure, Somnolence, |
||||
CANNABIDIOL, TOPIRAMATE, CLOBAZAM, |
||||
| 3835 | 26357651 |
EU |
67 | 2 |
Bradyarrhythmia, Atrioventricular block complete, Syncope, Seizure, |
||||
TICAGRELOR, TICAGRELOR, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 3836 | 26357878 |
TW |
51 | 2 |
Haemorrhage intracranial, Seizure, Cerebral infarction, Haemorrhagic transformation stroke, |
||||
BEVACIZUMAB, |
||||
| 3837 | 26358061 |
EU |
60 | 1 |
Seizure, Bundle branch block, Overdose, |
||||
| 3838 | 26358184 |
US |
||
Seizure, Alanine aminotransferase increased, Aspartate aminotransferase increased, Dizziness, Blood creatine phosphokinase increased, |
||||
AVUTOMETINIB POTASSIUM AND DEFACTINIB HYDROCHLORIDE, |
||||
| 3839 | 26358204 |
32 | ||
Seizure, |
||||
MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, DIVALPROEX SODIUM, |
||||
| 3840 | 26358254 |
GB |
75 | 2 |
Seizure, Hyponatraemia, |
||||
PANTOPRAZOLE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLOPIDOGREL, CLOPIDOGREL BISULFATE, RANOLAZINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 3841 | 26358412 |
12 | 1 | |
Seizure, Off label use, Drug ineffective for unapproved indication, |
||||
STIRIPENTOL, STIRIPENTOL, |
||||
| 3842 | 26358922 |
BR |
43 | 1 |
Seizure, Hypoaesthesia, Muscular weakness, Asthenia, Hypoaesthesia oral, Paraesthesia, Dyskinesia, Therapeutic product effect decreased, |
||||
GEFITINIB, ZOLEDRONIC ACID, |
||||
| 3843 | 26359130 |
7 | ||
Seizure, Hypersomnia, Somnolence, Decreased appetite, Product dose omission issue, |
||||
FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, DIVALPROEX SODIUM, |
||||
| 3844 | 26359200 |
|||
Seizure, |
||||
MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, |
||||
| 3845 | 26359678 |
US |
13 | 2 |
Pancreatitis, Seizure, Prescribed underdose, |
||||
TROFINETIDE, |
||||
| 3846 | 26359783 |
CH |
22 | 2 |
Seizure, |
||||
DISULFIRAM, LORAZEPAM, TRAZODONE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, QUETIAPINE, |
||||
| 3847 | 26359923 |
US |
34 | 1 |
Abdominal pain upper, Abdominal pain upper, Off label use, Seizure, Sedation, Nausea, Vomiting, |
||||
STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, CLOBAZAM, CLOBAZAM, |
||||
| 3848 | 26360017 |
US |
2 | |
Seizure, |
||||
| 3849 | 26360241 |
US |
2 | |
Seizure, Hypotension, Hypoventilation, Bradycardia, Acute kidney injury, Cardiac arrest, Coma, Hypervolaemia, Ventricular tachycardia, Toxicity to various agents, Intentional overdose, |
||||
METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, BUPROPION, |
||||
| 3850 | 26360675 |
CA |
||
Cardiac arrest, Delusion, Seizure, Loss of consciousness, Extra dose administered, |
||||
| 3851 | 26360922 |
50 | ||
Seizure, Product availability issue, Therapy interrupted, |
||||
BRIVARACETAM, BRIVARACETAM INJECTION, |
||||
| 3852 | 26360936 |
|||
Seizure, Anger, |
||||
LEVETIRACETAM, |
||||
| 3853 | 26360992 |
GB |
2 | |
Seizure, Anaphylactic reaction, |
||||
ATRACURIUM BESYLATE, |
||||
| 3854 | 26361009 |
CA |
74 | 2 |
Posterior reversible encephalopathy syndrome, Seizure, |
||||
RITUXIMAB, |
||||
| 3855 | 26361405 |
US |
2 | |
Seizure, Headache, |
||||
GALCANEZUMAB-GNLM, |
||||
| 3856 | 26361469 |
BR |
39 | 2 |
Seizure, Loss of consciousness, Headache, Dyspnoea, Malaise, Injection site erythema, Drug dose omission by device, |
||||
VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, TRAZODONE HYDROCHLORIDE, |
||||
| 3857 | 26361526 |
US |
3 | 1 |
Seizure, Blood glucose increased, COVID-19, Blood glucose fluctuation, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 3858 | 26361557 |
GB |
27 | 2 |
Seizure, |
||||
TIRZEPATIDE, |
||||
| 3859 | 26361569 |
US |
81 | 1 |
Seizure, Hypertension, Gait disturbance, Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 3860 | 26361636 |
23 | ||
Seizure, Diarrhoea, Irritability, Weight decreased, |
||||
FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, |
||||
| 3861 | 26361765 |
|||
Seizure, |
||||
| 3862 | 26361997 |
US |
69 | 2 |
Seizure, Nervousness, Back pain, Constipation, Dyspepsia, Nausea, Abdominal pain lower, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 3863 | 26366352 |
68 | 1 | |
Contrast media reaction, Seizure, Atrial fibrillation, Ventricular fibrillation, |
||||
SULFUR HEXAFLUORIDE, |
||||
| 3864 | 26366362 |
64 | 1 | |
Seizure, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, AMLODIPINE, LOSARTAN, |
||||
| 3865 | 26351104 |
US |
6 | 1 |
Hospitalisation, Seizure, Product administration interrupted, Off label use, |
||||
CANNABIDIOL, CANNABIDIOL, |
||||
| 3866 | 26351668 |
CO |
1 | 1 |
Seizure, |
||||
PALIVIZUMAB, |
||||
| 3867 | 26352584 |
US |
75 | 2 |
Dizziness, Pallor, Seizure, Heart rate increased, |
||||
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA, |
||||
| 3868 | 26352719 |
EU |
69 | 1 |
Drug interaction, Toxicity to various agents, Acute kidney injury, Seizure, Metabolic acidosis, Drug level increased, COVID-19, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, BASILIXIMAB, RITONAVIR, RITONAVIR 100 MG, |
||||
| 3869 | 26352889 |
US |
2 | |
Seizure, |
||||
PIMAVANSERIN TARTRATE, QUETIAPINE, |
||||
| 3870 | 26352967 |
CA |
2 | |
Seizure, |
||||
| 3871 | 26353126 |
US |
2 | |
Porocarcinoma, Skin mass, Metastases to soft tissue, Metastases to liver, Metastases to lymph nodes, Metastases to spleen, Metastases to lung, Metastases to bone, Metastases to meninges, Seizure, Nasal cavity cancer, Metastases to nervous system, Benign neoplasm of thyroid gland, |
||||
PREDNISONE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, EVEROLIMUS, EVEROLIMUS TABLETS, |
||||
| 3872 | 26353520 |
CN |
79 | 2 |
Seizure, |
||||
| 3873 | 26353730 |
CA |
71 | 1 |
Drug interaction, Seizure, |
||||
BUPROPION, EXTENDED PHENYTOIN SODIUM, ROSUVASTATIN, CITALOPRAM, CITALOPRAM HYDROBROMIDE, PANTOPRAZOLE, METHOTREXATE, METHOTREXATE SODIUM, FOLIC ACID, ERGOCALCIFEROL, |
||||
| 3874 | 26354139 |
US |
||
Seizure, Unadjusted dose administered, |
||||
ASFOTASE ALFA, |
||||
| 3875 | 26354166 |
US |
1 | |
Off label use, Product preparation issue, Off label use, Seizure, Sedation, |
||||
STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, CLOBAZAM, CLOBAZAM, LEVOCARNITINE, LEVOCARNITINE ORAL, LEVOCARNITINE, LEVOCARNITINE ORAL, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, PHENOBARBITAL, PHENOBARBITAL, MELATONIN, MELATONIN, IRON, IRON, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), LINACLOTIDE, LINACLOTIDE, ETHOSUXIMIDE, ETHOSUXIMIDE, RISPERIDONE, RISPERIDONE, RUFINAMIDE, RUFINAMIDE, ERGOCALCIFEROL, ERGOCALCIFEROL, MAGNESIUM, MAGNESIUM, |
||||
| 3876 | 26354218 |
US |
2 | |
Seizure, Eating disorder, Behaviour disorder, Overdose, Intentional product misuse, |
||||
DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 3877 | 26354460 |
KW |
50 | |
Death, Pyrexia, Disease progression, Arthralgia, Mass, Peripheral swelling, Confusional state, Hypokinesia, Eye movement disorder, Hyperchlorhydria, Ammonia increased, Seizure, Pain, Fatigue, Nausea, Somnolence, |
||||
SACITUZUMAB GOVITECAN, SACITUZUMAB GOVITECAN, SACITUZUMAB GOVITECAN, SACITUZUMAB GOVITECAN, |
||||
| 3878 | 26354461 |
CA |
2 | |
Asthenia, Dizziness, Fatigue, Somnolence, Seizure, Blood pressure increased, Neoplasm malignant, |
||||
OSIMERTINIB, |
||||
| 3879 | 26354464 |
US |
2 | |
Hospitalisation, Seizure, |
||||
CANNABIDIOL, CANNABIDIOL, |
||||
| 3880 | 26354474 |
US |
1 | |
Hospitalisation, Seizure, Partial seizures, Somnolence, Off label use, Therapy non-responder, |
||||
CANNABIDIOL, CANNABIDIOL, CANNABIDIOL, CANNABIDIOL, |
||||
| 3881 | 26354652 |
CN |
19 | 1 |
Seizure, Haematemesis, Dyspnoea, Nausea, Vomiting, Dizziness, Asthenia, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 3882 | 26354957 |
JP |
9 | 2 |
Haemolytic anaemia, Disseminated intravascular coagulation, Seizure, Shock, |
||||
MICAFUNGIN SODIUM, MICAFUNGIN SODIUM, FILGRASTIM, |
||||
| 3883 | 26354964 |
GB |
48 | 1 |
Cerebral haemorrhage, Bell^s palsy, Acute myocardial infarction, Speech disorder, Seizure, Headache, Hypoaesthesia, |
||||
PRASUGREL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BISOPROLOL FUMARATE, RAMIPRIL, LANSOPRAZOLE, NITROGLYCERIN, |
||||
| 3884 | 26355057 |
US |
5 | 2 |
Seizure, Balance disorder, Condition aggravated, Motor dysfunction, Migraine, Rash, Urticaria, Underdose, |
||||
TROFINETIDE, TROFINETIDE, |
||||
| 3885 | 26355747 |
|||
Seizure, Drug ineffective, |
||||
| 3886 | 26355752 |
MX |
53 | 2 |
Seizure, Platelet count decreased, Nausea, Vomiting, Immunodeficiency, Liver injury, Abdominal pain upper, Protein total decreased, Dilated cardiomyopathy, Feeling cold, Cardiomegaly, |
||||
VENETOCLAX, IBRUTINIB, |
||||
| 3887 | 26355837 |
US |
57 | 2 |
Seizure, Movement disorder, |
||||
LENALIDOMIDE, LENALIDOMIDE, |
||||
| 3888 | 26355932 |
CA |
40 | 2 |
Drug hypersensitivity, Seizure, |
||||
SECUKINUMAB, QUETIAPINE FUMARATE, QUETIAPINE, PREDNISONE, SULFASALAZINE, |
||||
| 3889 | 26356091 |
|||
Seizure, Muscle twitching, Impaired driving ability, Underdose, |
||||
LEVETIRACETAM, |
||||
| 3890 | 26356168 |
EU |
17 | 1 |
Seizure, Off label use, Drug ineffective for unapproved indication, |
||||
LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, TOPIRAMATE, ZONISAMIDE, ETHOSUXIMIDE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 3891 | 26356399 |
US |
23 | 2 |
Seizure, Syncope, Dizziness, Incorrect dose administered, |
||||
GALCANEZUMAB-GNLM, |
||||
| 3892 | 26357261 |
GB |
76 | 2 |
Seizure, |
||||
LINEZOLID, |
||||
| 3893 | 26357294 |
US |
3 | 2 |
Seizure, Product taste abnormal, Product odour abnormal, |
||||
LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, |
||||
| 3894 | 26359606 |
26 | 1 | |
Seizure, Impaired driving ability, Road traffic accident, Therapy cessation, |
||||
BUPROPION HYDROCHLORIDE, |
||||
| 3895 | 26360169 |
63 | 1 | |
Seizure, |
||||
CENOBAMATE, |
||||
| 3896 | 26343973 |
75 | ||
Seizure, Erythema, Pain of skin, Application site hypersensitivity, Off label use, |
||||
| 3897 | 26344118 |
US |
||
Seizure, Therapeutic product effect variable, |
||||
TROFINETIDE, |
||||
| 3898 | 26344149 |
US |
2 | |
Seizure, Spinal fracture, Fatigue, Drug ineffective, |
||||
INTERFERON BETA-1A, |
||||
| 3899 | 26344324 |
GB |
21 | 2 |
Oxygen saturation decreased, Seizure, |
||||
LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, BACLOFEN, CARBAMAZEPINE, CLOBAZAM, GABAPENTIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 3900 | 26344465 |
US |
70 | 2 |
Cerebrovascular accident, Pneumonia, Seizure, |
||||
DIROXIMEL FUMARATE, ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, ACETAMINOPHEN, DOXYLAMINE SUCCINATE, DEXTROMETHORPHAN HBR, ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, DOXYLAMINE SUCCINATE, ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE, ACETAMINOPHEN, DOXYLAMINE SUCCINATE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, HYDROCHLOROTHIAZIDE, TOPIRAMATE, AMLODIPINE BESYLATE, SPIRONOLACTONE, ACETAMINOPHEN, RIMEGEPANT SULFATE, GALCANEZUMAB-GNLM, LACOSAMIDE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ONABOTULINUMTOXINA, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30